🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with numerous of members share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of uncertain source.

Several professionals said the popularity for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has taken down violative material and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed guides for preparing or administering at residence.

Within minutes of entering one group, a vendor shared contact information, where the majority of purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Within these groups, posts show black plastic packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly serious medical dangers”.